Skip to main content
OpenTrials
Completed

NCT Number: NCT02868918

Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions

The aim of this study is to compare the effect of new bioactive dentine substitute (Biodentine) versus glass ionomer cement in very deep carious lesions clinically and radiographically using digital radiography in the terms of postoperative pain and biocompatibility to the pulp.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Omnia Magdy

Cairo, 02, Egypt

About this study

Roles and responsibilities:

  • Omnia Magdy Moustafa (O.M.) Operator, data entry & corresponding author; Assistant lecturer ,
  • Mohmed Riad Farid (M.R.) Main supervisor, data monitoring & auditing; Professor, Conservative Dentistry
  • Rasha Raffat (R.R.) Co-supervisor, data entry & auditing; Lecturer, Conservative Dentistry Department
  • Amir Hafez Ibrahim (A.H.), *Mohamed Refaat El-Bialy (M.E.) (A.H) Lecturer, Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University,(M.E.) Assistant lecturer , Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University outcome assessors and data collection.
  • Omar Shalaan (O.S.) Demonstrator, Conservative Dentistry Department, Faculty of Oral & Dental Medicine Cairo University, for baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents.

Interventions:

  • Pre-operative clinical assessment :
  • Thermal testing using Refrigerant spray
  • percussion test
  • Palpation and clinical examination
  • peri-apical radiographs using digital radiograph
  • Caries removal procedure:

Local anesthesia will be given to the patient then complete isolation to the tooth using rubber dame the operator O.M. will open the enamel Then in caries removal from the walls carbon-steel rose-head bur. Finally the deeper caries will be removed using spoon excavator

  • Intervention : Biodentine™ (Septodont, St. Maur-des-Fossés, France) The material will be applied according to manufacturer instructions
  • Comparator: GC Fuji IX GP (GC America Inc, Alsip, IL, USA) The material will be applied according to manufacturer instructions
  • Final restoration application:

Filtek™ Z250 Universal Restorative (3M Canada, London, Ontario Canada)

-Adhesive system: Scotchbond Universal Etchant (3M ESPE, St. Paul MN, USA) & Single Bond Universal adhesive (3M ESPE, St. Paul MN, USA).

  • The material will be applied according to manufacturer instruction

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients male or female older than 18 y in good general health
  • A minimum of 1 deep carious lesion penetrating three-quarters or more into the dentine as identified with the periapical (PA) radiograph; Clinically according to International Caries Detection and Assessment System (ICDAS II) score 4
  • Clinical symptoms of reversible pulpitis
  • Positive pulp response to electric pulp test or thermal stimulation
  • No PA changes viewed on PA radiograph

Exclusion criteria

  • Clinical symptoms of irreversible pulpitis requiring endodontic treatment
  • Presence of fistulas or swelling
  • Mobile teeth or tenderness to percussion
  • Anterior teeth with aesthetic concerns
  • Pregnant women, in view of requirements for radiographs
  • Patients younger than 18 y
  • Patients unable to give consent

Treatment and study plan

Biodentine

Drug

tricalcium silicate cement used to replace the carious dentin

Other names: tricalcium silicate

glass ionomer cement

Drug

high viscosity glass ionomer used as a base material

Other names: Fuji ix

DigoraH optium

Device

digital Xray for follow up

Other names: digital radiography

Primary outcomes

  1. postoperative hypersensitivity using yes or no questionnaire

    Time frame: 6 months

Secondary outcomes

  1. Biocompatibility of biodentine using digital X-ray

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical and Radiographical Evaluation of New Bioactive Dentine Substitute (Biodentine) Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions -Randomized Clinical Trial

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Aug 16, 2016
Registry last updated
Sep 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.